PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 23 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Elemi essential oil and its nanoparticles demonstrate antiproliferative effects [PMID:37285457]
Elemi essential oil identified as having high activity against the stationary phase of the bacterium [PMID:31801196]
Elemi essential oil shows activity against both growing and stationary phase S. aureus [PMID:32209108]
C. luzonicum essential oil showed dose-dependent antifungal activity against clinical isolates from the human oral cavity [PMID:27330531]
Evidence summary
PubMed sources
- 1.PMID: 37285457 (2023) — Elemi essential oil nanocapsulated drug ameliorates lung cancer via oxidative stress, apoptosis and inflammation pathway. · Journal of cellular and molecular medicine
- 2.PMID: 36725928 (2023) — Biomolecular analyses enable new insights into ancient Egyptian embalming. · Nature
- 3.PMID: 31801196 (2019) — Essential Oils with High Activity against Stationary Phase Bartonella henselae. · Antibiotics (Basel, Switzerland)
- 4.PMID: 42197248 (2026) — Isolation and Structural Elucidation of Phytochemicals from Canarium luzonicum Leaves and Evaluation of Anti-Lung Cancer and Antileishmanial Activity. · Molecules (Basel, Switzerland)
- 5.PMID: 17345315 (1986)